Fixing Hemophilia B With Gene Therapy

BLOOD(2006)

引用 0|浏览5
暂无评分
摘要
A critical element for treatment of hemophilia B via gene therapy is sustained transgene expression. This study describes novel AAV vectors, optimized for expression in the liver, that generate sustained, therapeutic levels of factor IX expression in nonhuman primates.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要